A double dose of deal data:
Series B data is below, to follow up on the Series A data that just went out.
If you know someone planning on raising an A or B in the next six months, forward this along to them. Thanks for reading!
The Amazing Shrinking B
In August of 2021, 10% of Series Bs raised over $100M (15 deals).
In August of 2022, 7% of Series Bs raised over $100M (6 deals).
In August of 2023, not a single B crossed the $100M mark.
It’s one thing to see deal volumes fall by 2/3rds in two years. It’s quite another to see an entire class of deals vanish.
Series B Deals
Summary Stats
Data for Series B deals done worldwide (ex-China) where amount raised is greater than $5M and the company is not focused on therapeutics.